Keyphrases
Population-based
100%
High-risk Human Papillomavirus (HR-HPV)
100%
Cluster Randomized Trial
100%
Human Papillomavirus Vaccine
100%
Vaccine Effectiveness
100%
Cancer Population
100%
Cervical Cancer
44%
Cancer Cases
44%
HPV16
33%
Vaccination
22%
Human Papillomavirus Types
22%
Tongue Cancer
22%
Invasive Cancer
22%
HPV 52
22%
Vulvar Cancer
22%
Vaginal Cancer
22%
Tumor
11%
Clinical Trials
11%
Trial Registration
11%
Follow-up Time
11%
Intention-to-treat
11%
Placebo
11%
Cancer Registry
11%
Risk Factors
11%
Type-specific
11%
Older Women
11%
Unvaccinated
11%
HPV6
11%
HPV18
11%
HPV-45
11%
PATRICIA
11%
HPV33
11%
Medicine and Dentistry
Malignant Neoplasm
100%
Wart Virus
100%
Vaccine
100%
Cluster Randomized Trial
100%
Cervical Cancer
30%
Human Papillomavirus Type 16
23%
Tumor Invasion
15%
Tongue Cancer
15%
Human Papillomavirus Type 52
15%
Vagina Cancer
15%
Diagnosis
7%
Neoplasm
7%
Clinical Trial
7%
Intention-to-Treat Analysis
7%
Placebo
7%
Cancer Registry
7%
Wart Virus Vaccine
7%
Human Papillomavirus Type 6
7%
Human Papillomavirus Type 18
7%
Human Papillomavirus Type 45
7%
Human Papillomavirus Type 33
7%
Vulvar Cancer
7%